| 000 | 01584 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517165657.0 | ||
| 264 | 0 | _c20190102 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1468-2079 | ||
| 024 | 7 |
_a10.1136/bjophthalmol-2017-310822 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWykoff, Charles C | |
| 245 | 0 | 0 |
_aNeovascular age-related macular degeneration management in the third year: final results from the TREX-AMD randomised trial. _h[electronic resource] |
| 260 |
_bThe British journal of ophthalmology _c04 2018 |
||
| 300 |
_a460-464 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aChoroidal Neovascularization _xdrug therapy |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMacular Degeneration _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRanibizumab _xtherapeutic use |
| 650 | 0 | 4 | _aVisual Acuity |
| 700 | 1 | _aOu, William C | |
| 700 | 1 | _aCroft, Daniel E | |
| 700 | 1 | _aPayne, John F | |
| 700 | 1 | _aBrown, David M | |
| 700 | 1 | _aClark, W Lloyd | |
| 700 | 1 | _aAbdelfattah, Nizar Saleh | |
| 700 | 1 | _aSadda, SriniVas R | |
| 773 | 0 |
_tThe British journal of ophthalmology _gvol. 102 _gno. 4 _gp. 460-464 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bjophthalmol-2017-310822 _zAvailable from publisher's website |
| 999 |
_c27436986 _d27436986 |
||